Journal
JOURNAL OF ARTHROPLASTY
Volume 35, Issue 7, Pages S32-S36Publisher
CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
DOI: 10.1016/j.arth.2020.04.038
Keywords
COVID-19; elective orthopaedic surgery; econonomics; volume; patient demand; technology and innovation
Categories
Funding
- American Association of Hip and Knee Surgeons
- Aerobiotix
Ask authors/readers for more resources
Background: The economic effects of the COVID-19 crisis are not like anything the U.S. health care system has ever experienced. Methods: As we begin to emerge from the peak of the COVID-19 pandemic, we need to plan the sustainable resumption of elective procedures. We must first ensure the safety of our patients and surgical staff. It must be a priority to monitor the availability of supplies for the continued care of patients suffering from COVID-19. As we resume elective orthopedic surgery and total joint arthroplasty, we must begin to reduce expenses by renegotiating vendor contracts, use ambulatory surgery centers and hospital outpatient departments in a safe and effective manner, adhere to strict evidence-based and COVID-19-eadjusted practices, and incorporate telemedicine and other technology platforms when feasible for health care systems and orthopedic groups to survive economically. Results: The return to normalcy will be slow and may be different than what we are accustomed to, but we must work together to plan a transition to a more sustainable health care reality which accommodates a COVID-19 world. Conclusion: Our goal should be using these lessons to achieve a healthy and successful 2021 fiscal year. (C) 2020 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available